You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Efficacy of small-incision intraocular lens exchange of opacified Hydroview implants
  1. Takefumi Yamaguchi1,2,
  2. Tsutomu Shimizu1,
  3. Kazuko Yamaguchi1,
  4. Murat Dogru3,
  5. Kazuno Negishi1,
  6. Kazuo Tsubota1
  1. 1Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan
  2. 2Department of Ophthalmology, Tokyo Dental College, Chiba, Japan
  3. 3J&J Ocular Surface and Visual Optics Department, Keio University School of Medicine, Tokyo, Japan
  1. Correspondence toMr Takefumi Yamaguchi, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo 160-8582, Japan; yama19770614{at}hotmail.com

https://doi.org/10.1136/bjo.2008.155234

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Opacification of Hydroview intraocular lens (IOL) has been reported to result in visual impairment and become one of the reasons for IOL exchange.1–4 Although IOL exchange has been reported to be of visual benefit, the surgery is technically challenging because of its intraoperative complications, including rupture of the posterior capsule, zonulysis, iris prolapse and vitreous loss.1 2 5 The trisection technique was reported to be useful, which allows explantation of IOLs through a small incision and reduces the risk of complications.6 The purpose of this study is to evaluate the efficacy of small-incision trisection technique in Hydroview IOL exchange.

    Case reports

    The retrospective clinical interventional case series study included consecutive 32 eyes of 25 patients with opacified Hydroview IOL, who underwent IOL exchange. The mean age was 76.7±9.8 years old, with a range of 57–90 years. In …

    View Full Text

    Footnotes

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval Ethics approval was provided by the ethics board of Keio University.

    • Provenance and peer review Not commissioned; externally peer reviewed.